The Japanese Pharmaceutical Group (JPG) is the voice of the Japanese life sciences industry in the UK - made up of eleven companies whose global HQs are based in Japan.

JPG is the champion of UK life sciences in Japan and seeks to partner with Government to promote the UK as a competitive location for Japanese investment.

At present our members employ a total of 2400 people across European offices that are based here, as well as UK affiliates. JPG companies are investing in therapeutic innovation in NHS disease area priorities including cardiovascular diseases, dementia and new antibiotics, in gene therapy, digital health technology and AI.

Latest News

UK-Japan Life Sciences R&D Roundtable 19 February 2021

Find more information about this meeting hosted by Lord Bethell, Minister for Innovation, and Professor Sir John Bell for Japanese Pharmaceutical Group R&D Heads here